IL-6 is produced in response to local proinflammatory cytokines such as TNF-α, within the tumor microenvironment and can activate JAK/STAT3, MAPK, and PI3K/AKT pathways (Johnson et al., 2018). The gene discussed is IL6; the disease is neoplasm.